BPC-157 for Neuropathy Research — Mechanism & Evidence Peripheral neuropathy affects over 20 million people globally, and current pharmaceutical treatments primarily mask symptoms without addressing nerve damage itself.…
Read articleSermorelin Sarcopenia Research Mechanism Explained A 2023 multi-center trial published in the Journal of Clinical Endocrinology & Metabolism found that sarcopenic adults over 65 treated with 500mcg sermorelin nightly fo…
Read articleDoes Sermorelin Help Sarcopenia Research? (2026 Evidence) A 2023 rodent trial published in Aging Cell found that sermorelin administration increased lean mass by 11.2% in aged mice over 12 weeks. But only when combined …
Read articleSermorelin for Sarcopenia Research — Peptide Mechanisms A 2024 cohort study published in the Journal of Cachexia, Sarcopenia and Muscle found that sermorelin-treated subjects demonstrated 12% greater lean mass retention…
Read articleMK-677 Studied Sarcopenia Research — Clinical Evidence Research from the University of Virginia published in 2008 found that 25mg daily MK-677 produced statistically significant lean mass gains of 1.1kg in elderly popul…
Read articleMOTS-C Support Weight Loss Without GLP-1? (Science-Backed Answer) A 2015 study published in Cell Metabolism by researchers at the University of Southern California identified MOTS-c (Mitochondrial Open Reading Frame of …
Read articleDoes MOTS-C Support Fat Loss Optimization? (Evidence) A 2015 study published in Cell Metabolism found that MOTS-C administration in mice increased running capacity by 20% and prevented diet-induced obesity even on a hig…
Read articleMOTS-c for Fat Loss Optimization — Mitochondrial Peptide Research conducted at the University of Southern California identified MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) as a 16-amino-acid peptide enco…
Read articleBPC-157 Studied IBS — What Research Shows (2026 Data) Research conducted at the University of Zagreb found that BPC-157 accelerated healing of experimentally induced colitis in rats by modulating vascular endothelial gr…
Read articleBPC-157 IBS Mechanism — How It Targets Gut Inflammation Research from the University of Zagreb's Department of Pharmacology identified something counterintuitive about BPC-157: it doesn't act like traditional anti-infla…
Read articleBPC-157 for IBS — Does It Work? (Clinical Evidence) Irritable bowel syndrome (IBS) has no shortage of supplements claiming to 'restore gut health'. Most of them do nothing. BPC-157 stands apart because the animal resear…
Read articleDoes BPC-157 Help IBS? — Research-Backed Evidence Over 45 million people in the US experience irritable bowel syndrome, yet fewer than 5% achieve lasting symptom relief with standard pharmacological treatment. The gap i…
Read articleMOTS-c Studied Insulin Resistance Research — Key Findings Research published in Cell Metabolism (2015) identified MOTS-c as the first mitochondrial-derived peptide shown to improve insulin sensitivity in skeletal muscle…
Read articleMOTS-c for Insulin Resistance Research — Mechanism Guide Research published in Cell Metabolism identified MOTS-c as a mitochondrial-derived peptide that directly activates AMPK (AMP-activated protein kinase). The master…
Read articleMOTS-c Insulin Resistance Research Mechanism Explained MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid peptide encoded in mitochondrial DNA that activates AMPK (AMP-activated protein kinas…
Read articleDoes MOTS-c Help Insulin Resistance Research? — Real Peptides A 2015 study published in Cell Metabolism identified MOTS-c as the first mitochondrially-encoded peptide with direct metabolic regulatory effects. Specifical…
Read articleDoes Tesamorelin Help Metabolic Syndrome Research? Research published in The Lancet Diabetes & Endocrinology found that tesamorelin reduced visceral adipose tissue by 15.2% over 26 weeks in HIV-associated lipodystrophy …
Read articleMOTS-c Metabolic Syndrome Research Mechanism Explained Most mitochondrial-derived peptides get dismissed as niche research compounds with unclear clinical relevance. MOTS-c (Mitochondrial Open Reading Frame of the 12S r…
Read articleMOTS-c Studied Metabolic Syndrome Research — Findings A 2015 study published in Cell Metabolism by researchers at USC identified a 16-amino-acid mitochondrial-derived peptide that reversed insulin resistance in mice fed…
Read articleTesamorelin for Metabolic Syndrome Research — Key Findings Research conducted at Massachusetts General Hospital found that tesamorelin reduced visceral adipose tissue (VAT) by 15.2% in HIV-associated lipodystrophy patie…
Read article